TrialAnnals of oncology : official journal of the European Society for Medical Oncology2020

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma.

T K Choueiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.